Impact of an Institution‐Specific Hospital‐Acquired Pneumonia Protocol on the Appropriateness of Antibiotic Therapy and Patient Outcomes
暂无分享,去创建一个
S. Nasraway | J. Devlin | E. Garpestad | Jeffrey J. Fong | S. Doron | Jason W. Lancaster | Jason W. Lancaster | Kenneth R. Lawrence | Jeffrey J. Fong | Shira I. Doron | Erik Garpestad | Stan A. Nasraway | John W. Devlin | K. Lawrence
[1] J. Devlin,et al. The Effect of ICU Sedation Guidelines and Pharmacist Interventions on Clinical Outcomes and Drug Cost , 1997, The Annals of pharmacotherapy.
[2] Jordi Rello,et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.
[3] Larry J. Anderson,et al. Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, Respiratory care.
[4] 古谷 良輔,et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.
[5] M. Kollef. Gram-negative bacterial resistance: evolving patterns and treatment paradigms. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] G Sherman,et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.
[7] S. Weingarten,et al. Guidelines in pulmonary medicine: a 25-year profile. , 1999, Chest.
[8] J. Gums,et al. A Randomized, Prospective Study Measuring Outcomes after Antibiotic Therapy Intervention by a Multidisciplinary Consult Team , 1999, Pharmacotherapy.
[9] J. Rello,et al. De-escalation in lower respiratory tract infections , 2006, Current opinion in pulmonary medicine.
[10] Marin H Kollef,et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.
[11] T. Karchmer,et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. , 2006, Chest.
[12] J. Rello,et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy* , 2007, Critical care medicine.
[13] C. Bridges,et al. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[14] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[15] D. Craven,et al. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. , 1995, Chest.
[16] Jessina C. McGregor,et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] D. Cardo,et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.
[18] Leonard Leibovici,et al. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.
[19] A. Arroliga,et al. Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: Physician and nurse adherence , 2000, Critical care medicine.
[20] D A Rasley,et al. Surveillance of nosocomial infections , 1989, Critical care nursing quarterly.
[21] D. Cook,et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.
[22] Victoria J. Fraser,et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* , 2003, Critical care medicine.
[23] J. Burke,et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Matthew Bidwell Goetz,et al. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. , 2005, Chest.
[25] L. Leibovici,et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. , 2004, BMJ.
[26] M. Perreault,et al. Impact of a Protocol for Prevention of Ventilator-Associated Pneumonia , 2007, The Annals of pharmacotherapy.
[27] Mauricio Valencia,et al. Ventilator-associated pneumonia , 2009, Current opinion in critical care.
[28] Claude D Martin,et al. Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse* , 2007, Critical care medicine.
[29] M. Niederman,et al. Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome* , 2003, Critical care medicine.
[30] Acip. Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .